From petri dish to patient:biotech’s formidable obstacle course
Bulls N’ Bears follows a biotech breakthrough from the laboratory to the patient and examines how Australian companies are negotiating the hurdles along the way.
We haven't written up this one. The Age has the full story — the link below goes straight to it.